[Form 4] IonQ, Inc. Insider Trading Activity

Rhea-AI Filing Summary

IonQ, Inc. (IONQ) – Form 4 Insider Transaction

Chief Financial Officer Thomas G. Kramer reported the sale of 43,382 shares of IonQ common stock on 07 July 2025 at a weighted-average price of $47.73 per share under a Rule 10b5-1 trading plan adopted on 14 March 2025. Following the transaction, Kramer’s direct holdings stand at 603,134 shares, with an additional 5 shares held indirectly for a child.

The disposition represents roughly 6-7 % of the executive’s pre-trade direct position and generated proceeds of approximately $2.1 million. No derivative security activity was reported. The filing indicates the transaction was executed as part of a pre-arranged plan, which can reduce signaling concerns but still reduces insider exposure to the stock.

Positive

• Executive retains 603,134 shares post-sale, indicating continued equity alignment with shareholders.
• Transaction executed under a 10b5-1 plan, reducing potential concerns about trading on material non-public information.

Negative

• CFO disposed of 43,382 shares (≈6-7% of holdings) for ~$2.1 million, which some investors may interpret as a bearish signal.

Insights

Securities Analyst

TL;DR: CFO sells ~43k IONQ shares (~$2.1M) via 10b5-1; modest reduction, still holds 600k+, impact limited.

The sale removes about 6-7% of Mr. Kramer’s direct stake, indicating a partial monetization rather than an exit. Because the trade was executed under a previously adopted 10b5-1 plan, the informational content is muted; such plans are often used for diversification. The remaining 603k-share holding suggests continued alignment with shareholders. From a valuation or liquidity standpoint, the transaction is immaterial to IonQ’s capital structure and should not affect fundamental analysis, but short-term traders may view any C-suite sale as a mild negative sentiment signal.

Corporate Governance Expert

TL;DR: Pre-planned trade limits governance concern; insider still retains significant ownership.

Use of a 10b5-1 plan satisfies best-practice guidelines by insulating the transaction from non-public information claims. The filing meets Section 16(a) timeliness, and footnotes provide price ranges, improving transparency. Insider ownership post-sale remains meaningful, supporting ongoing alignment with shareholders. Overall governance impact is neutral.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kramer Thomas G.

(Last) (First) (Middle)

C/O IONQ, INC.

4505 CAMPUS DRIVE

(Street)

COLLEGE PARK MD 20740

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IonQ, Inc. [ IONQ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
07/08/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/08/2025		S(1)		43,382	D	$47.7291(2)	603,134	D
Common Stock								5	I	By child

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2025.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.70 to $47.83, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

	/s/ Kevin Caimi, Attorney-in-Fact	07/10/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many IonQ (IONQ) shares did the CFO sell?

Thomas G. Kramer sold 43,382 shares of common stock.

At what price were the IonQ shares sold?

The weighted-average sale price was $47.73, with individual trades between $47.70 and $47.83.

Does the CFO still hold IonQ shares after the sale?

Yes. He now directly owns 603,134 shares and indirectly owns 5 shares for a child.

Was the sale made under a 10b5-1 plan?

Yes. The filing states the trades were executed under a Rule 10b5-1 plan adopted on 14 March 2025.

Is this transaction likely to affect IonQ's fundamentals?

No. The sale represents personal diversification; it does not involve the company’s balance sheet or operations.

When was the Form 4 filed?

The Form 4 was signed on 10 July 2025.